| A Nov 25
article in the NY Times calls Connecticut
"Stem Cell Central." The work of UConn's
David Rowe and Ren-He Xu, and Yale's Haifan Lin and
Michael Snyder, is noted. more |
|
|
| Events
Column |
|
| 2/7 Alternative
Products and Green Chemistry: Challenges and Opportunities
of the New Global Marketplace. Northeast Utilities
Conference Center, Berlin, CT. more |
|
| 2/12 3:00
pm - 6:00 pm. CURE and Yale OCR Present: Rib-X. A BioHaven
Entrepreneurship Seminar. Anlyan Center, Congress Avenue,
New Haven, CT. Reception and networking to follow.
Watch for details. |
|
| 3/19 3:00
pm - 6:00 pm. CURE and Yale OCR Present: Optherion. A BioHaven
Entrepreneurship Seminar. Anlyan Center, Congress Avenue,
New Haven, CT. Reception and networking to follow. more |
|
| 3/26 Connecticut
Innovations Annual Technology Celebration. The Aqua Turf
Club, Southington, CT. more |
|
| 4/11 8:00
am - 6:30 pm. Healthcare 2008 at the Yale School of
Management. "Whose Healthcare is it Anyway?
Understanding the Patient as a Consumer." Omni Hotel,
New Haven, CT. more |
|
| 4/16 3:30
pm - 6:00 pm. CURE and Yale OCR Present: The Next Big
Idea - Creating a New Venture. A Special BioHaven
Entrepreneurship Panel with Roger Longman of Windhover
Publications. Reception and networking to follow. Anlyan
Center, Congress Avenue, New Haven, CT. more |
|
| 4/23 3:00
pm - 6:00 pm. CURE and Yale OCR Present: Vidus Ocular. A BioHaven
Entrepreneurship Seminar. Anlyan Center, Congress Avenue,
New Haven, CT. Reception and networking to follow. more |
|
|
|
Stem
Cell Breakthroughs Make the News
From
the desk of Paul Pescatello, President and CEO of CURE
 Last
month I wrote that Connecticut’s wise decision to embrace
stem cell research was continuing to pay dividends. In the
past few weeks, breaking news attests even further to the
wisdom of that decision. To begin with, Haifan Lin and his
stem cell center at Yale have succeeded in attracting another
of the world's leading bioscientists to our state.
Meanwhile, those following stem cell research were fascinated
to read of experiments that point towards a promising
alternative route to generating stem cells.
For
the full story |
|
BioRelix
& Vascular Insights Launch BioHaven Series
 The
Yale BioHaven Entrepreneurship Series, presented by CURE and
Yale OCR, launched its 2007-2008 schedule with
presentations by two local Yale spin-outs: BioRelix, which
is developing antibiotics that target microbial RNA, and
Vascular Insights, which will market a new device for
treating varicose vein disease.
For
the full story |
|
CURE
Member News Digest
 454
Life Sciences announces publication of over 100
studies Achillion
reports on 3Q progress
Alexion
named winner of CURE Award of Excellence
Bayer
HealthCare reports Nexavar® approval
Boehringer
Ingelheim named top employer
Bristol-Myers
Squibb reports AVALIDE® progress
Cara
Therapeutics marks Shelton opening
Connecticut
Innovations names board members
CuraGen
comments on 3Q position
Genomas
reports pain research
GlaxoSmithKline
changes Avandia® label
Hartford
Hospital gets organ donation recognition
HistoRx to
use funding for AQUA® platform
Invitrogen benefits
from defense bill
Ipsogen
announces mutation tool kit
Johnson
& Johnson reports ZYRTEC® approval
MannKind
continues with inhalable insulin
NanoViricides
reports rabies progress
Neurogen foresees
advances in 4Q
Pfizer
to acquire Coley Pharmaceutical Group
PhRMA
reports on fight against staph infections
Discovery
magazine cites Protein Sciences Corporation
vaccine
Rib-X
to present at Feb 12 BioHaven
VaxInnate
gains from defense bill
Vion
confirms Cloretazine® goals
Winstanley
buys 25 Science Park
UConn
names professor to BI endowed chair
Yale
gets funding for cancer center
For
the full story |
|
